Evidence map›Paper›PMID 36417230›Full record

ArticleEpidemiologia (Basel, Switzerland)2021

The COVID-19 Vaccination Strategy in Brazil-A Case Study.

Llanos Bernardeau-Serra, Agathe Nguyen-Huynh, Lara Sponagel, Nathalia Sernizon Guimarães, Raphael Augusto Teixeira de Aguiar, Milena Soriano Marcolino

Abstract read
In one paragraph

Article in Epidemiologia (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Antibody Response in Healthcare Workers During the SARS-CoV-2 Gamma Variant Outbreak in Manaus, Brazil.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Observational
  15. Effect of vaccination against Covid-19 one year after its introduction in Brazil.Tropical diseases, travel medicine and vaccines · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Llanos Bernardeau-SerraGlobal Studies Institute, Université de Genève, 1211 Geneva, Switzerland.ORCID 0000-0001-8994-1082
Agathe Nguyen-HuynhGlobal Studies Institute, Université de Genève, 1211 Geneva, Switzerland.
Lara SponagelGlobal Studies Institute, Université de Genève, 1211 Geneva, Switzerland.
Nathalia Sernizon GuimarãesInfectious Disease and Tropical Medicine Postgraduation Program, Medical School, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil.ORCID 0000-0002-0487-0500
Raphael Augusto Teixeira de AguiarDepartment of Public Health, Medical School, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil.ORCID 0000-0002-5285-1742
Milena Soriano MarcolinoDepartment of Internal Medicine, Medical School, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil.ORCID 0000-0003-4278-3771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazil is among the countries which have faced two devastating infection waves of COVID-19 in the past year. Despite the fact the country has one of the world's leading immunization programs, Brazil only slowly established a national COVID-19 vaccination strategy and campaign. This case study is based on an integrative review of primary and secondary literature sources. Different search strategies on Medline and Google Scholar were performed for the case presentation, for the management and outcome of the COVID-19 outbreak and for the state of the COVID-19 vaccination program. Official documents from the Brazilian Ministry of Health, the website of the World Health Organization and pharmaceutical companies were also reviewed. Searches were limited to English, French, German, Portuguese and Spanish. This article describes the Brazilian COVID-19 vaccination campaign and the drivers and barriers to its implementation; and evaluates further investigations needed to have a conclusive overview over the constantly evolving situation. Healthcare inequalities, which were widened during the pandemic, a lack of coordination at the federal level, the absence of federal government support for scientific research and the lack of endorsement and commitment to the mitigation of the COVID-19 pandemic set the country's COVID-19 vaccination campaign off to a challenging start. However, Brazil had a well-developed primary care system and national vaccination program prior to the pandemic, which are both important facilitators. At the time of writing, six vaccines are currently available in the country, and the program is advancing. The scientific community needs to continue to investigate the country's vaccination strategy and its implementation to make sure that maximum effort is undertaken for the health of the Brazilian population.

Indexed as

BrazilCOVID-19disease managementmass vaccinationpandemic

Identifiers

PMID36417230
PMCPMC9620893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.